Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Testosterone helps human pancreatic cells increase insulin release.

Researchers found specific genes in the part of hair follicles that could help treat hair disorders.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Iron deficiency might contribute to hair loss in women.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Women with irregular periods have a higher risk of heart disease.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Pantethine may boost the immune system's ability to fight sarcoma.

Tiny RNA molecules help control the growth of plant hairs.